Product Code: ETC8848034 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pancreatic and biliary stents market in the Philippines is primarily driven by the need to manage obstructions due to cancers or chronic pancreatitis. Hospitals and specialty centers are increasing the use of minimally invasive procedures like ERCP (endoscopic retrograde cholangiopancreatography), where stents play a crucial role. Market growth is supported by improved healthcare infrastructure and increasing awareness among gastroenterologists.
This market is growing in the Philippines as advanced gastrointestinal and hepatobiliary treatments become more accessible. Hospitals and diagnostic centers are adopting minimally invasive techniques, including stent placements, for managing obstructions due to cancers or gallstone disease. The trend towards shorter recovery times and reduced surgical complications is a key market driver.
This market is constrained by high procedure costs and limited access to advanced stenting technologies in public hospitals. There is a lack of trained specialists and modern surgical equipment in many regions, restricting patient access to minimally invasive procedures. Import dependency also results in supply chain delays and high costs for healthcare providers.
The pancreatic and biliary stents market in the Philippines is witnessing growth due to the increasing incidence of pancreatic and bile duct disorders. Investment opportunities lie in the distribution of advanced stent designs, local manufacturing partnerships, and expanding minimally invasive surgery centers. There is also potential in providing training programs and endoscopic equipment support to public and private hospitals to improve procedural capacity and access.
The use of biliary stents in hospitals is governed by the DOH and FDA. All medical devices must be registered under the ASEAN Medical Device Directive. The government ensures hospital access to these devices through PhilHealth coverage, especially for cancer-related procedures, and encourages public-private partnerships to enhance surgical infrastructure.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Pancreatic and Biliary Stents Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Pancreatic and Biliary Stents Market - Industry Life Cycle |
3.4 Philippines Pancreatic and Biliary Stents Market - Porter's Five Forces |
3.5 Philippines Pancreatic and Biliary Stents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Pancreatic and Biliary Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Philippines Pancreatic and Biliary Stents Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Philippines Pancreatic and Biliary Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Pancreatic and Biliary Stents Market Trends |
6 Philippines Pancreatic and Biliary Stents Market, By Types |
6.1 Philippines Pancreatic and Biliary Stents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Plastic Stents, 2021- 2031F |
6.1.4 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Metal Stents, 2021- 2031F |
6.2 Philippines Pancreatic and Biliary Stents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Benign Biliary structures, 2021- 2031F |
6.2.3 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Biliary Leaks, 2021- 2031F |
6.2.4 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.5 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Philippines Pancreatic and Biliary Stents Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Philippines Pancreatic and Biliary Stents Market Revenues & Volume, By Other End-Users, 2021- 2031F |
7 Philippines Pancreatic and Biliary Stents Market Import-Export Trade Statistics |
7.1 Philippines Pancreatic and Biliary Stents Market Export to Major Countries |
7.2 Philippines Pancreatic and Biliary Stents Market Imports from Major Countries |
8 Philippines Pancreatic and Biliary Stents Market Key Performance Indicators |
9 Philippines Pancreatic and Biliary Stents Market - Opportunity Assessment |
9.1 Philippines Pancreatic and Biliary Stents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Pancreatic and Biliary Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Philippines Pancreatic and Biliary Stents Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Philippines Pancreatic and Biliary Stents Market - Competitive Landscape |
10.1 Philippines Pancreatic and Biliary Stents Market Revenue Share, By Companies, 2024 |
10.2 Philippines Pancreatic and Biliary Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |